DCF — BAPTIST HEALTH LEXINGTON
Enterprise Value: $69.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$69.3M
Enterprise Value
$0.7M
PV of Cash Flows
$68.6M
PV of Terminal Value
$110.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $783.4M | $25.7M | 3.0% | $-9.0M | $-8.2M |
| Year 2 | $806.9M | $34.6M | 4.0% | $-3.2M | $-2.6M |
| Year 3 | $831.1M | $43.9M | 5.0% | $2.9M | $2.2M |
| Year 4 | $856.0M | $49.5M | 6.0% | $6.2M | $4.3M |
| Year 5 | $881.7M | $53.2M | 6.0% | $8.1M | $5.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $69.3M. Terminal value accounts for 99% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$760.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.027837345206917236
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5